Skip to main content
. 2020 Feb 3;12(2):126. doi: 10.3390/pharmaceutics12020126

Figure 1.

Figure 1

Molecular structure of CAT3 (A) as the pro-drug, PF403 (B) as the active in vivo metabolite, and (+)-Deoxytylophorinine (CAT) (C) as the internal standard (ISTD) of the drug concentration test in plasma.